Forbion Raises Record 2.3 Billion Euros Across Two Venture Funds
European biotech venture firm Forbion has closed 2.3 billion euros in capital across two funds to invest in high-potential biotechnology startups.
FTMQ Startups, written by our newsroom0 views
European venture capital firm Forbion has raised 2.3 billion euros, or approximately 2.6 billion dollars, across two new biotech funds. Alternatives Watch and BioPharma Dive both reported that the total represents the firm’s largest fundraising haul to date, exceeding its previous record. Fierce Biotech, FirstWord Pharma, and The Business Journals also reported on the landmark fundraise. [1][2][3][4][5][6]
According to BioPharma Dive, the capital was collected across Forbion Growth Opportunities IV and Forbion Ventures Fund VIII. Fierce Biotech reported that the firm plans to use the capital to support approximately 30 high-potential biotechnology companies. [3][4]
BioPharma Dive reported that the capital injection provides a significant boost for the European biotechnology sector, which has fallen further behind competing markets in the United States and China. [3]
In short
- Forbion raised 2.3 billion euros, equivalent to 2.6 billion dollars, across two venture funds.
- The two vehicles involved are Forbion Growth Opportunities IV and Forbion Ventures Fund VIII.
- Fierce Biotech reported that the total capital pool is intended to support around 30 biotechs.
Sources
Every paragraph above points to the numbered items it rests on. Read the originals here.
- [1]Forbion tops predecessor haul with €2.3bn dual fundraiseAlternatives Watch, 45d ago (the report this story comes from)
- [2]Forbion, a prominent biotech investor, raises $2.6B for a pair of venture fundsBioPharma Dive, 45d ago
- [3]Forbion, a prominent biotech investor, raises $2.6B for a pair of venture fundsBioPharma Dive, 45d ago
- [4]Forbion’s ‘landmark’ €2.3B fundraise to benefit 30 ‘high potential’ biotechsFierce Biotech, 46d ago
- [5]Forbion raises 'record' €2.3B for new biotech fundsFirstWord Pharma, 46d ago
- [6]Forbion raises $2.6B for biotech investments, its largest fundraising to dateThe Business Journals, 45d ago
Background
- [7]Simon J. Clark on Wikipedia
Our newsroom writes these reports with the help of software, from the 7 sources listed and nothing else, and checks them against those sources. Facts can still be wrong or move on; the originals are the record. Spotted a mistake? Write to daniel@monsterkong.com.
Related from FTMQ Startups
Earlier reports of ours on the same people and subjects.
- Forbion co-founder warns European biotech lacks early stage venture capitalVenture Capital, 1d ago
- Vintage Investment Partners Raises 920 Million Dollars Across Two VehiclesVenture Capital, 29d ago
- Blue Sea Capital closes fourth fund at 800 million dollarsVenture Capital, 3d ago
- Blueprint Equity raised third fund in 12 days amid tight marketVenture Capital, 8d ago
- Nebraska startups log 21 venture capital deals in third quarterTop Stories, 16d ago
More in Venture Capital
- Los Angeles Pension Commits Additional 30 Million Dollars to Townsend Real Estate15h ago
- Oberland Capital Healthcare Solutions II reports 796 million dollars raised15h ago
- Forbion co-founder warns European biotech lacks early stage venture capital1d ago
- Foundry Investment Management closes third fund at 120 million dollars1d ago
- Pegasus Tech Ventures and Taisei Corporation Launch 150 Million Dollar CVC Initiative3d ago
- Blue Sea Capital closes fourth fund at 800 million dollars3d ago
Get the day in one email
Reports like this one, the top news of the last 24 hours, every morning. Free, one email a day; readers can comment under every report.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.

Comments
Loading
Join the conversation
Comments are open to readers of our daily email: the top news of the last 24 hours, every morning, free. Sign up and the comment box opens.
Already on the list? Enter the same address and we will send a sign-in link.
By signing up you agree to our terms and privacy policy. Unsubscribe any time.